CymitQuimica logo

CAS 1194508-25-2

:

Edivoxetine

Description:
Edivoxetine, with the CAS number 1194508-25-2, is a selective norepinephrine reuptake inhibitor (NRI) primarily investigated for its potential use in treating attention-deficit hyperactivity disorder (ADHD) and other related conditions. It functions by increasing the levels of norepinephrine in the synaptic cleft, which can enhance attention and focus. Edivoxetine is characterized by its chemical structure, which includes specific functional groups that contribute to its pharmacological activity. The substance is typically administered in oral form and has been studied for its efficacy and safety profile in clinical trials. Its side effects may include insomnia, dry mouth, and increased heart rate, which are common among NRIs. As with any medication, the therapeutic use of Edivoxetine should be guided by a healthcare professional, considering individual patient needs and potential interactions with other medications. Overall, Edivoxetine represents a targeted approach in the pharmacotherapy of ADHD, aiming to improve cognitive function and quality of life for affected individuals.
Formula:C18H26FNO4
InChI:InChI=1S/C18H26FNO4/c1-22-16-3-2-15(19)10-13(16)11-18(21,14-4-7-23-8-5-14)17-12-20-6-9-24-17/h2-3,10,14,17,20-21H,4-9,11-12H2,1H3/t17-,18+/m0/s1
InChI key:InChIKey=CPBHSHYQQLFAPW-ZWKOTPCHSA-N
SMILES:[C@@](CC1=C(OC)C=CC(F)=C1)(O)(C2CCOCC2)[C@@]3(CNCCO3)[H]
Synonyms:
  • (αR,2S)-α-[(5-Fluoro-2-methoxyphenyl)methyl]-α-(tetrahydro-2H-pyran-4-yl)-2-morpholinemethanol
  • 2-Morpholinemethanol, α-[(5-fluoro-2-methoxyphenyl)methyl]-α-(tetrahydro-2H-pyran-4-yl)-, (αR,2S)-
  • Edivoxetine
  • LY 2216684
  • (R)-2-(5-fluoro-2-methoxyphenyl)-1-((S)-morpholin-2-yl)-1-(tetrahydro-2H-pyran-4-yl)ethan-1-ol
Sort by
The purity filter is not visible because current products do not have associated purity data for filtering.
Found 1 products.